Cargando…
Orally Bioavailable Prodrugs of ψ-GSH: A Potential Treatment for Alzheimer’s Disease
[Image: see text] Addressing glycation-induced oxidative stress in Alzheimer’s disease (AD) is an emerging pharmacotherapeutic strategy. Restoration of the brain glyoxalase enzyme system that neutralizes reactive dicarbonyls is one such approach. Toward this end, we designed, synthesized, and evalua...
Autores principales: | Xie, Wei, Cao, Bin, Zhu, Haizhou, Raza, Abbas, Juckel, Nicholas, Xie, Jiashu, Jiang, Rongrong, Vince, Robert, Lee, Michael K., More, Swati S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662183/ https://www.ncbi.nlm.nih.gov/pubmed/36353871 http://dx.doi.org/10.1021/acs.jmedchem.2c00779 |
Ejemplares similares
-
Dipeptide of ψ-GSH Inhibits Oxidative Stress and Neuroinflammation in an Alzheimer’s Disease Mouse Model
por: Raza, Abbas, et al.
Publicado: (2022) -
γ-Glutamyl-Transpeptidase-Resistant Glutathione Analog Attenuates Progression of Alzheimer’s Disease-like Pathology and Neurodegeneration in a Mouse Model
por: Christopher Kwon, Ye In, et al.
Publicado: (2021) -
An Orally Bioavailable (Mice) Prodrug of Glutathione
por: Crankshaw, Daune L., et al.
Publicado: (2021) -
Sulfanegen stimulates 3-mercaptopyruvate sulfurtransferase activity and ameliorates Alzheimer's disease pathology and oxidative stress in vivo
por: Rao, Swetha Pavani, et al.
Publicado: (2022) -
The Alleviation of LPS-Induced Murine Acute Lung Injury by GSH-Mediated PEGylated Artesunate Prodrugs
por: Hao, Dan-Li, et al.
Publicado: (2022)